(Q23912822)

Biochimica et Biophysica Acta: Reviews on Cancer

inferred from title

process of elimination

publication date

December 2009

0 references

published in

0 references

volume

1796

0 references

issue

2

0 references

page(s)

242-251

0 references

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

cites work

The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Selective interaction of JNK protein kinase isoforms with transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Molecular targeted therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Involvement of reactive oxygen species in aflatoxin B1-induced cell injury in cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Redox events in interleukin-1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Inhibitors of c-Jun N-terminal kinases: JuNK no more?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

JNK1 regulates histone acetylation in trigeminal neurons following chemical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

The JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Novel advancements in the management of hepatocellular carcinoma in 2008.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Protein kinase p-JNK is correlated with the activation of AP-1 and its associated Jun family proteins in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Nonproteolytic functions of ubiquitin in cell signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

HBx modulates iron regulatory protein 1-mediated iron metabolism via reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Analysis of signaling protein kinases in human colon or colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

TNFalpha and reactive oxygen species in necrotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

A small molecule-kinase interaction map for clinical kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Targeting JNK for therapeutic benefit: from junk to gold?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Dominant negative MEKK1 inhibits survival of pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Liver stem cells and their implication in hepatocellular and cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Expression pattern of a newly recognized protein, LECT2, in hepatocellular carcinoma and its premalignant lesion

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Hepatocellular carcinoma: recent trends in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Pivotal role of mTOR signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

1Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Gene expression patterns in human liver cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/beta-catenin signaling through GSK3beta pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Liver cancer biomarkers struggling to succeed

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Alternative splicing and bioinformatic analysis of human U12-type introns.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Novel concepts in hepatocellular carcinoma: from molecular research to clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Molecularly targeted therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Hepatobiliary transporter expression in human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Viral hepatocarcinogenesis: from infection to cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Reactive oxygen special (ROS), troublemakers between nuclear factor-kB (NF-kB) and c-Jun NH2-terminal kinase (JNK)

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Reversible Smad-dependent signaling between tumor suppression and oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Paxillin comes of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

The H19 non-coding RNA is essential for human tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Canonical and alternative MAPK signaling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021

Beyond apoptosis of JNK1 in liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBCAN.2009.06.005

7 January 2021